Ivsins A, Mansoor M, Bowles J, Bardwell G Reasons for enrolling in safer supply programs: a longitudinal qualitative study on participant goals and related outcomes in the MySafe program J Stud Alcohol Drugs PubMed

Ivsins A, Bowles JM, Mansoor M, Kerr T, Bardwell G Repurposing prescribed hydromorphone: alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs Int J Drug Policy PubMed

Chayama KL, Ti L, Arredondo Sanchez Lira J, Coulaud PJ, Bardwell G, Knight R Opportunities and challenges for implementing drug checking services in British Columbia, Canada: a qualitative study Int J Drug Policy PubMed

Bardwell G, Mansoor M, van Zwietering A, Cleveland E, Snell D, Kerr T Correction: The "goldfish bowl": a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting Harm Reduct J PubMed

Bardwell G, Ivsins A, Wallace JR, Mansoor M, Kerr T "The machine doesn't judge": Counternarratives on surveillance among people accessing a safer opioid supply via biometric machines Soc Sci Med PubMed

Bowles J, Mansoor M, Werb D, Kerr T, Bardwell G A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: motivations and initial impacts J Subst Use Addict Treat PubMed

Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: a qualitative analysis Int J Drug Policy PubMed